Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI

References

• Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30: 96–102
   PubMedGoogle Scholar
• Bear HD, Anderson S, Smith RE, Geyer CE, Jr, Mamounas EP, Fisher B, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006; 24: 2019–27
   PubMed Web of Science ®Google Scholar
• Warren RM, Bobrow LG, Earl HM, Britton PD, Gopalan D, Purushotham AD, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer 2004; 90: 1349–60
   PubMedGoogle Scholar
• Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2003; 181: 1275–82
   PubMed Web of Science ®Google Scholar
• Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. Am J Roentgenol 2002; 179: 1193–9
   PubMed Web of Science ®Google Scholar
• Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kuhn T. Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 2002; 12: 1711–9
   PubMed Web of Science ®Google Scholar
• Denis F, Desbiez-Bourcier AV, Chapiron C, Arbion F, Body G, Brunereau L. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 2004; 30: 1069–76
   PubMedGoogle Scholar
• Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM. MRI vs histologic measurement of breast cancer following chemotherapy; comparison with x-ray mammography and palpation. J Magn Reson Imaging 2001; 13: 868–75
   PubMed Web of Science ®Google Scholar
• Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001; 8: 549–59
   PubMedGoogle Scholar
• Choi N, Han BK, Choe YH, Kim HS. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction. J Comput Assist Tomogr 2005; 29: 834–41
   PubMedGoogle Scholar
• Wasser K, Sinn HP, Fink C, Klein SK, Junkermann H, Ludemann HP, et al. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 2003; 13: 1213–23
   PubMed Web of Science ®Google Scholar
• Rieber A, Zeitler H, Rosenthal H, Gorich J, Kreienberg R, Brambs HJ, et al. MRI of breast cancer: Influence of chemotherapy on sensitivity. Br J Radiol 1997; 70: 452–8
   PubMed Web of Science ®Google Scholar
• Tsuboi N, Ogawa Y, Inomata T, Yoshida D, Yoshida S, Moriki T, et al. Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: Pathologic correlation. Oncol Rep 1999; 6: 727–32
   PubMedGoogle Scholar
• Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging. J Clin Oncol 1999; 17: 110–9
   PubMed Web of Science ®Google Scholar
• Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 2002; 86: 1041–6
   PubMed Web of Science ®Google Scholar
• Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 2003; 84: 192–7
   PubMed Web of Science ®Google Scholar
• Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15: 2483–93
   PubMed Web of Science ®Google Scholar
• Kim R, Osaki A, Toge T. Current and future roles of neoadjuvant chemotherapy in operable breast cancer. Clin Breast Cancer 2005; 6: 223–32
   PubMedGoogle Scholar
• Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. Am J Roentgenol 2005; 184: 868–77
   PubMed Web of Science ®Google Scholar
• Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PE. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 2003; 9: 355–62
   PubMed Web of Science ®Google Scholar
• Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: Characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003; 76: 3–12
   PubMed Web of Science ®Google Scholar
• Viehweg P, Lampe D, Buchmann J, Heywang-Kobrunner SH. In situ and minimally invasive breast cancer: Morphologic and kinetic features on contrast- enhanced MR imaging. MAGMA 2000; 11: 129–37
   PubMedGoogle Scholar
• Liberman L, Morris EA, Lee MJ, Kaplan JB, LaTrenta LR, Menell JH, et al. Breast lesions detected on MR imaging: Features and positive predictive value. Am J Roentgenol 2002; 179: 171–8
   PubMed Web of Science ®Google Scholar
• Hylton N. Magnetic resonance imaging of the breast: Opportunities to improve breast cancer management. J Clin Oncol 2005; 10: 1678–84
   Google Scholar
• Delille J-P, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: Noninvasive monitoring with functional MR imaging pilot study. Radiology 2003; 228: 63–9
   PubMed Web of Science ®Google Scholar